Status:
RECRUITING
Dexmedetomidine vs Ketamine as Adjuvants to Bupivacaine in Transversus Abdominus Plane Block in Inguinal Hernioplasty
Lead Sponsor:
Ain Shams University
Conditions:
Postoperative Pain Relief
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
This clinical trial aims to compare the effect of adding dexmedetomidine versus ketamine to bupivacaine in transversus abdominis plane block in patients undergoing unilateral inguinal hernioplasty. Th...
Detailed Description
Preoperative Assessment: Patients scheduled for unilateral inguinal hernioplasty will be assessed preoperatively by evaluating their medical history, laboratory investigations, and fulfillment of the...
Eligibility Criteria
Inclusion
- Patients undergoing unilateral inguinal hernioplasty of ASA I or II.
- Age group: 18-60 years old.
Exclusion
- Patient refusal.
- known allergy to any of the used drugs
- ASA III or above
- Coagulation disorders and thrombocytopenia
- Body mass index (BMI) \>30
- Infection at needle insertion site
- Patients undergoing bilateral inguinal hernioplasty
Key Trial Info
Start Date :
October 22 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07194694
Start Date
October 22 2025
End Date
January 30 2026
Last Update
December 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Hospitals
Cairo, Egypt